Mitochondrial oxidative damage contributes to a wide range of pathologies. One therapeutic strategy to treat these disorders is targeting antioxidants to mitochondria by conjugation to the lipophilic triphenylphosphonium (TPP) cation. To date only hydrophobic antioxidants have been targeted to mitochondria; however, extending this approach to hydrophilic antioxidants offers new therapeutic and research opportunities. Here we report the development and characterization of MitoC, a mitochondria-targeted version of the hydrophilic antioxidant ascorbate. We show that MitoC can be taken up by mitochondria, despite the polarity and acidity of ascorbate, by using a sufficiently hydrophobic link to the TPP moiety. MitoC reacts with a range of reactive species, and within mitochondria is rapidly recycled back to the active ascorbate moiety by the glutathione and thioredoxin systems. Because of this accumulation and recycling MitoC is an effective antioxidant against mitochondrial lipid peroxidation and also decreases aconitase inactivation by superoxide. These findings show that the incorporation of TPP function can be used to target polar and acidic compounds to mitochondria, opening up the delivery of a wide range of bioactive compounds. Furthermore, MitoC has therapeutic potential as a new mitochondria-targeted antioxidant, and is a useful tool to explore the role(s) of ascorbate within mitochondria.

Department of Chemistry University of Otago P O Box 56 Dunedin 9054 New Zealand

Laboratory for Metabolism and Bioenergetics 3rd Faculty of Medicine Charles University 100 00 Prague 10 Czech Republic

MRC Mitochondrial Biology Unit Wellcome Trust MRC Building Cambridge CB2 0XY UK

Zobrazit více v PubMed

Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009;417:1–13. PubMed PMC

Murphy M.P. Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. Antiox. Redox Signal. 2012;16:476–495. PubMed

Smith R.A.J., Hartley R.C., Cochemé H.M., Murphy M.P. Mitochondrial pharmacology. Trends Pharmacol. Sci. 2012;33:341–352. PubMed

Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A.J., Murphy M.P. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 2001;276:4588–4596. PubMed

Smith R.A.J., Murphy M.P. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals N. Y. Acad. Sci. 2010;1201:96–103. PubMed

Snow B.J., Rolfe F.L., Lockhart M.M., Frampton C.M., O'Sullivan J.D., Fung V., Smith R.A.J., Murphy M.P., Taylor K.M. A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease. Movement Dis. 2010;25:1670–1674. PubMed

Gane E.J., Weilert F., Orr D.W., Keogh G.F., Gibson M., Lockhart M.M., Frampton C.M., Taylor K.M., Smith R.A.J., Murphy M.P. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver Int. 2010;30:1019–1026. PubMed

Smith R.A.J., Hartley R.C., Murphy M.P. Mitochondria-targeted small molecule therapeutics and probes. Antiox. Redox Signal. 2011;15:3021–3038. PubMed

Du J., Cullen J.J., Buettner G.R. Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim. Biophys. Acta. 2012;1826:443–457. PubMed PMC

Carr A., Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J. 1999;13:1007–1024. PubMed

Cuddihy S.L., Parker A., Harwood D.T., Vissers M.C., Winterbourn C.C. Ascorbate interacts with reduced glutathione to scavenge phenoxyl radicals in HL60 cells. Free Radic. Biol. Med. 2008;44:1637–1644. PubMed

Winkler B.S. Unequivocal evidence in support of the nonenzymatic redox coupling between glutathione/glutathione disulfide and ascorbic acid/dehydroascorbic acid. Biochim. Biophys. Acta. 1992;1117:287–290. PubMed

Packer J.E., Slater T.F., Willson R.L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 1979;278:737–738. PubMed

Niki E. Role of vitamin E as a lipid-soluble peroxyl radical scavenger: in vitro and in vivo evidence. Free Radic. Biol. Med. 2014;66:3–12. PubMed

Li X., Cobb C.E., Hill K.E., Burk R.F., May J.M. Mitochondrial uptake and recycling of ascorbic acid. Arch. Biochem. Biophys. 2001;387:143–153. PubMed

Munoz-Montesino C., Roa F.J., Pena E., Gonzalez M., Sotomayor K., Inostroza E., Munoz C.A., Gonzalez I., Maldonado M., Soliz C., Reyes A.M., Vera J.C., Rivas C.I. Mitochondrial ascorbic acid transport is mediated by a low-affinity form of the sodium-coupled ascorbic acid transporter-2. Free Rad. Biol. Med. 2014;70:241–254. PubMed

Lee Y.C., Huang H.Y., Chang C.J., Cheng C.H., Chen Y.T. Mitochondrial GLUT10 facilitates dehydroascorbic acid import and protects cells against oxidative stress: mechanistic insight into arterial tortuosity syndrome. Hum. Mol. Gen. 2010;19:3721–3733. PubMed

Ross M.F., Kelso G.F., Blaikie F.H., James A.M., Cochemé H.M., Filipovska A., Da Ros T., Hurd T.R., Smith R.A.J., Murphy M.P. Lipophilic triphenylphosphonium cations as tools in mitochondrial bioenergetics and free radical biology. Biochemistry (Mosc) 2005;70:222–230. PubMed

Finichiu P.G., James A.M., Larsen L., Smith R.A.J., Murphy M.P. Mitochondrial accumulation of a lipophilic cation conjugated to an ionisable group depends on membrane potential, pH gradient and pKa: implications for the design of mitochondrial probes and therapies. J. Bioenerg. Biomembr. 2013;45:165–173. PubMed

Terajima T., Takai T., Nakamura H. Modified ion exchange resins with higher selectivity in bisphenol preparation. 2006 WO 2006003803 A1 20060112.

Wimalasena K., Dharmasena S., Wimalasena D.S., Hughbanks-Wheaton D.K. Reduction of dopamine beta-monooxygenase. A unified model for apparent negative cooperativity and fumarate activation. J. Biol. Chem. 1996;271:26032–26043. PubMed

Ju-Nam Y., Allen D.W., Gardiner P.H.E., Bricklebank N. ω-Thioacetylalkylphosphonium salts: precursors for the preparation of phosphonium-functionalised gold nanoparticles. J. Organometal. Chem. 2008;693:3504–3508.

Markowski T., Drescher S., Meister A., Hause G., Blume A., Dobner B. Synthesis of optically pure diglycerol tetra-ether model lipids with non-natural branching pattern. Eur. J. Org. Chem. 2011;29:5894–5904.

Grotjahn D.B., Larsen C.R., Gustafson J.L., Nair R., Sharma A. Extensive isomerization of alkenes using a bifunctional catalyst: an alkene zipper. J. Amer. Chem. Soc. 2007;129:9592–9593. PubMed

Clark T.D., Dugan E.C. Preparation of oligo(ethylene glycol)-terminated icosanedisulfides. Synthesis. 2006:1083–1086.

Asin-Cayuela J., Manas A.R., James A.M., Smith R.A.J., Murphy M.P. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Letts. 2004;571:9–16. PubMed

Ohkawa H., Ohishi N., Yagi K. Reaction of linoleic acid hydroperoxide with thiobarbituric acid. J. Lipid Res. 1978;19:1053–1057. PubMed

Brand M.D. Measurement of mitochondrial protonmotive force. In: Brown G.C., Cooper C.E., editors. Bioenergetics-a practical approach. IRL; Oxford: 1995. pp. 39–62.

Beer S.M., Taylor E.R., Brown S.E., Dahm C.C., Costa N.J., Runswick M.J., Murphy M.P. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defense. J. Biol. Chem. 2004;279:47939–47951. PubMed

Hurd T.R., Collins Y., Abakumova I., Chouchani E.T., Baranowski B., Fearnley I.M., Prime T.A., Murphy M.P., James A.M. Inactivation of pyruvate dehydrogenase kinase 2 by mitochondrial reactive oxygen species. J. Biol. Chem. 2012;287:35153–35160. PubMed PMC

James A.M., Cochemé H.M., Smith R.A.J., Murphy M.P. Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem. 2005;280:21295–21312. PubMed

Ross M.F., Da Ros T., Blaikie F.H., Prime T.A., Porteous C.M., Severina I.I., Skulachev V.P., Kjaergaard H.G., Smith R.A.J., Murphy M.P. Accumulation of lipophilic dications by mitochondria and cells. Biochem. J. 2006;400:199–208. PubMed PMC

Lillig C.H., Berndt C., Holmgren A. Glutaredoxin systems. Biochim. Biophys. Acta. 2008;1780:1304–1317. PubMed

Holmgren A., Johansson C., Berndt C., Lonn M.E., Hudemann C., Lillig C.H. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem. Soc. Trans. 2005;33:1375–1377. PubMed

May J.M., Mendiratta S., Hill K.E., Burk R.F. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J. Biol. Chem. 1997;272:22607–22610. PubMed

Prime T.A., Forkink M., Logan A., Finichiu P.G., McLachlan J., Li Pun P.B., Koopman W.J., Larsen L., Latter M.J., Smith R.A.J., Murphy M.P. A ratiometric fluorescent probe for assessing mitochondrial phospholipid peroxidation within living cells. Free Rad. Biol. Med. 2012;53:544–553. PubMed

Cochemé H.M., Murphy M.P. Complex I is the major site of mitochondrial superoxide production by paraquat. J. Biol. Chem. 2008;283:1786–1798. PubMed

Toth I., Bridges K.R. Ascorbic acid enhances ferritin mRNA translation by an IRP/aconitase switch. J. Biol. Chem. 1995;270:19540–19544. PubMed

Toth I., Rogers J.T., McPhee J.A., Elliott S.M., Abramson S.L., Bridges K.R. Ascorbic acid enhances iron-induced ferritin translation in human leukemia and hepatoma cells. J. Biol. Chem. 1995;270:2846–2852. PubMed

Mitochondria-Targeted Honokiol Confers a Striking Inhibitory Effect on Lung Cancer via Inhibiting Complex I Activity